Form 8-K - Current report:
SEC Accession No. 0001193125-20-097142
Filing Date
2020-04-03
Accepted
2020-04-03 08:16:02
Documents
1
Period of Report
2020-04-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d884625d8k.htm 8-K 21766
  Complete submission text file 0001193125-20-097142.txt   22804
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 20771709
SIC: 2834 Pharmaceutical Preparations